MIRA INFORM REPORT

 

 

Report Date :

17.11.2014

 

IDENTIFICATION DETAILS

 

Name :

JOHNSON AND JOHNSON LIMITED

 

 

Registered Office :

Lal Bahadur Shastri Marg, Mulund (West), Mumbai – 400080, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

05.09.1957

 

 

Com. Reg. No.:

11-010928

 

 

Capital Investment / Paid-up Capital :

Rs. 144.000 Millions

 

 

CIN No.:

[Company Identification No.]

U33110MH1957PLC010928

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AAACJ1067F

 

 

PAN No.:

[Permanent Account No.]

AAACJ0866E

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of consumer and hospital products.

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Aa (72)

 

RATING

STATUS

PROPOSED CREDIT LINE

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

 

Maximum Credit Limit :

USD 35000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a well-established and reputed company having fine track record.

 

As per registrar of companies the date of Balance Sheet (i.e. financial filed) is shown as 31.03.2014 but the documents related to financials are not available for any source.

 

As per available financial of 2013, the rating reflects company’s healthy operational risk profile supported by decent brand name with diversified product portfolio, strong financial base and adequate profitability margins of the company.

 

Trade relations are reported as trustworthy. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had illfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

 

EXTERNAL AGENCY RATING

 

Not Available

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED

 

Management non co-operative (91-22-66646464)

 

LOCATIONS

 

Registered Office :

Lal Bahadur Shastri Marg, Mulund (West), Mumbai – 400080, Maharashtra, India

Tel. No.:

91-22-23861431 / 24241431/23861451 / 66646464

Fax No.:

91-22-23871482 / 23801482

E-Mail :

info@jnjindia.com

psoneji@jnjindia.com

sales@jnjindia.com

smoorthy@jnjin.jnj.com

contactus@jnjindia.com

Website :

http://www.jnjindia.com

 

 

DIRECTORS

 

As on: 22.08.2014

 

Name :

Mr. Sanjiv Hari Navangul

Designation :

Whole Time Director

Address :

No.4, Kismat Perry Cross Road and Kantiwadi Road, Nandra West, Mumbai – 400050, Maharashtra, India

Date of Birth/Age :

26.12.1964

Date of Appointment :

28.11.2013

DIN No.:

02924640

 

 

Name :

Mr. Sushobhan Dasgupta

Designation :

Whole Time director

Address :

Care of Johnson and Johnson Limited, 30 Forjett Street, Mumbai – 400 036, Maharashtra, India

Date of Birth/Age :

02.12.1962

Date of Appointment :

27.09.2012

DIN No.:

06381955

 

 

Name :

Mr. Anil Vasantrai Upadhyay

Designation :

Whole Time Director

Address :

Flat No.42, Alka Building, Major Parmeshwaraan Road, Opposite SIWS College Wadala, Mumbai – 400 031, Maharashtra, India

Date of Birth/Age :

22.09.1958

Date of Appointment :

25.09.2012

DIN No.:

00236635

 

 

Name :

Mr. Suresh Vikas Srivastava

Designation :

Managing Director

Address :

Vivarea 40 th Floor, Jacob Cirle Sane Gyruji Marg, Mumbai – 400011, Maharashtra, India

Date of Birth/Age :

03.12.1969

Date of Appointment :

14.06.2014

DIN No.:

06923769

 

 

 

KEY EXECUTIVES

 

Name :

Mr. Anil Vasantrai Upadhyay

Designation :

Secretary

Address :

Flat No.42, Alka Building, Major Parmeshwaraan Road, Opposite SIWS College Wadala, Mumbai – 400 031, Maharashtra, India

Date of Birth/Age :

22.09.1958

Date of Appointment :

01.09.2000

PAN No.:

AAAPU0992M

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 22.08.2014

 

Name of Shareholders

No. of Shares

%age

http://www.bseindia.com/include/images/clear.gifJohnson and Johnson, USA

1,080,000

75.00

Depuy Medical Private Limited, India

360,000

25.00

Total

1,440,000

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 30.09.2014

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

75.00

Bodies corporate

 

25.00

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of consumer and hospital products

 

 

Products :

Product Description

 

Item Code No. (ITC Code)

Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure

30061010

Baby, moisturizing lotion, hair oil, Other-Gift boxes

33049120

Sanitary napkins; Tampons

48030010

 

 

Brand Names :

Not Avalable

 

 

Agencies Held :

Not Avalable

 

 

Exports :

Not Avalable

 

 

Imports :

Not Avalable

 

 

Terms :

 

Selling :

Not Available

 

 

Purchasing :

Not Available

 

 

GENERAL INFORMATION

 

Suppliers :

Not Available

 

 

Customers :

Not Available

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

Bankers :

The Hong Kong and the Shanghai Banking Corporation Limited, 52/60, Mahatma Gandhi Road, Fort, Mumbai – 400 001, Maharashtra, India

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Lovelock and Lewes

Chartered Accountants

Address :

252, Veer Savarkar Marg, Shivaji Park, Dadar , Mumbai – 400 028, Maharashtra, India

PAN No.:

AABFL5878L

 

 

Holding and Ultimate Holding Company:

Johnson and Johnson, USA

 

 

Subsidiaries:

  • Deshraj Investments and Trading Company Limited (CIN No.: U65990MH1981PLC023828)
  • Key to Riches Investment and Leasing Limited (CIN No.: U67120MH1987PTC043329)
  • Loyalty Investments and Enterprises Limited (CIN No.: U67120MH1984PTC032582)
  • Suryalay Investment and Trading Company Limited (CIN No.: U65990MH1981PLC023690)
  • NR Jet Enterprises Limited [U24239MH1981PLC025232]

 

 

Enterprises having significant influence and a subsidiary of the holding company:

  • Depuy Medical Private Limited

 

 

Fellow Subsidiaries / Associate Enterprises with whom the Company has transactions:

 

 

  • ASP Services, Inc.
  • Johnson and Johnson Vision Care (Ireland) Limited
  • Biosense Webster Inc.
  • Johnson and Johnson K.K.
  • Cordis Corporation
  • Johnson and Johnson Sdn. Bhd.
  • Ethicon Endo Surgery Inc
  • Johnson and Johnson (Philippines) Inc.
  • Ethicon Inc.
  • Johnson and Johnson Russia Limited
  • JANSSEN SUPPLY GROUP, LLC.
  • Johnson and Johnson Private Limited
  • Johnson and Johnson Consumer Inc.
  • Johnson and Johnson International (Singapore) Private Limited
  • Johnson and Johnson HCS Inc
  • Cilag GmbH International
  • Johnson and Johnson International
  • Johnson and Johnson (HK) Limited Taiwan Branch
  • Janssen Research and Development, LLC
  • Johnson and Johnson (Thailand) Limited
  • Codman and Shurtleff Inc
  • Johnson and Johnson Middle East
  • Johnson and Johnson Services Inc.
  • European Logistics Center
  • Johnson and Johnson Vision Care, Inc.
  • Mentor Medical Systems, C.V.
  • Lifescan Inc.
  • PP SUD Limited
  • McNeilPPC, Inc.
  • Medos Sarl
  • Advanced Technologies and Regenerative Medicine, LLC
  • OCD US
  • Mentor Worldwide LLC
  • Depuy Orthopaedics. Inc.
  • Mentor Texas LP
  • Acclarent, Inc.
  • Johnson and Johnson (China) Limited
  • Johnson and Johnson Medical Shanghai Limited
  • Janssen Cilag S.p.A.
  • Janssen Pharmaceutical K.K.
  • Janssen Korea, Limited
  • Johnson and Johnson Medical Korea (Limited)
  • Janssen Biologics BV
  • Janssen Cilag Limited
  • Johnson and Johnson (Vietnam) Company, Limited
  • Johnson and Johnson Medical Limited
  • Fka Ethicon Limited
  • Depuy (Ireland) Limited
  • Johnson and Johnson Medical Private Limited
  • Johnson and Johnson Medical N.V. (formerly Cordis I)
  • GMED Healthcare BVBA
  • J.C. General Services CVBA (U.S. $)
  • Janssen Pharmaceutica N.V.
  • Representative Office of Janssen Pharmaceutica NV
  • Ethicon Puerto Rico LLC
  • Ethicon Endo Surgery, LLC
  • Johnson and Johnson do Brasil
  • Indústria e Comércio de Produtos para Saúde Limiteda
  • LifeScan Scotland Limited
  • Ortho Clinical Diagnostics S.A.
  • Medos International Sarl
  • Obtech Medical AG fka Obtech Medical AG
  • Biosense Israel Limited
  • EES Holdings de Mexico S. de R.L. de C.V.
  • Johnson and Johnson G.m.b.H.
  • Johnson and Johnson (Hong Kong) Limited
  • P.T. Johnson and Johnson Indonesia

 

 

List of Fellow Subsidiaries /

Associate Enterprises :

  • Cordis LLC
  • Calisto Limited
  • Janssen Ortho LLC
  • Synthes Tibbi Cihazlar Sanayi Ve Ticaret Limited
  • Ortho Biologics LLC
  • JOHNSON AND JOHNSON SIHHI MALZEME SAN. VE TIC. Limited STI.
  • OMJ Ireland
  • Johnson and Johnson Medikal Sanayi Ve Ticaret Limited Sirketi
  • Ethicon Ireland
  • Finsbury Orthopaedics Tibbi Cihazlar Ticaret Limited
  • ASP Services, Inc.
  • Anspach Europe Limited
  • Albany Street LLC
  • SYNTHES Limited
  • Alza Corporation
  • Johnson and Johnson Medical Limited fka Ethicon Limited
  • Alza Development Corporation
  • Janssen Cilag Limited
  • Alza Land Management Inc.
  • Syntaxin Limited
  • Artemis Medical Inc.
  • RespiVert Limited
  • Atrionix Inc.
  • Depuy (Ireland) Limited
  • Babycenter Advertising LLC
  • Johnson and Johnson S.E., Inc.
  • Slovenia BabyCenter LLC
  • Johnson and Johnson d.o.o. Croatia
  • Biosense Webster Inc.
  • Johnson and Johnson d.o.o
  • Biotechnology Research Partners Limited
  • Johnson and Johnson Bulgaria EOOD
  • BRP Inc.
  • Janssen Cilag
  • Centocor Research and Development
  • Johnson and Johnson (Private) Limited
  • Janssen Biotech, Inc.
  • SYNTHES Argentina S.A.
  • Company Store.com Inc
  • Janssen Cilag Farmaceutica S.A.
  • Cordis Corporation
  • Johnson and Johnson Medical S.A.
  • Cordis Development Corporation
  • Johnson and Johnson de Argentina S.A.C.e.l. LuMend Inc.
  • Synthes Australia Private Limited
  • Cordis International Corporation
  • Johnson and Johnson Private Limited
  • Cordis Neurovascular Inc.
  • Johnson and Johnson Pacific Private Limited
  • Crescendo Pharmaceuticals Corporati
  • McNeil Manufacturing Private Limited
  • DeltaGlide Inc.
  • Janssen Cilag Private Limited
  • Depuy Development Inc.
  • Johnson and Johnson Research Private Limited
  • Depuy Mitek Inc.
  • Penta Private Limited
  • Depuy Orthopaedics. Inc.
  • Tasmanian Alkaloids Private Limited
  • Depuy Products Inc.
  • SYNTHES New Zealand Limited
  • Depuy Spine Holding Corporation
  • Johnson and Johnson Medical Private Limited
  • Depuy Spine Limited Partnership
  • Depuy Australia
  • Depuy Inc.
  • Depuy New Zealand
  • Diabetes Diagnostics Inc.
  • Johnson and Johnson Medical Products GmbH
  • EES Holding Company Inc.
  • Johnson and Johnson Gesellschaft M.B.H.
  • Egea Biosciences LLC
  • Synthes Limited
  • Endovascular Therapeutics Research
  • SODIAC ESV
  • Ethicon Endo Surgery Services L.P.
  • Johnson and Johnson Medical N.V. (formerly Cordis I)
  • Ethicon Endo Surgery Inc
  • Johnson and Johnson NCB
  • Ethicon Endo Surgery LLC
  • GMED Healthcare BVBA
  • Cordis Financing J.C. General Services CVBA (U.S. $)
  • Therakos , Inc.
  • Cordis Holding Belgium BVBA
  • Ethicon Inc.
  • Janssen Pharmaceutica N.V.
  • JANSSEN SUPPLY GROUP, LLC.
  • Representative Office of Janssen Pharmaceutica NV
  • Golden Triangle Dev. Corp.
  • J and J International Financial Services Company
  • Golden Triangle Urban Ren. Associate
  • Tibotec Virco Comm. VA
  • GynoPharma Inc.
  • Virco BVBA
  • Heartport Inc.
  • Janssen Infectious Diseases Diagnostics BVBA
  • I.D. Acquisition Corp
  • Ortho Clinical Diagnostics N.V.
  • Independence Technology L.L.C.
  • Janssen R and D Ireland
  • Integ Corporation
  • Tibotec, Inc. (USA)
  • ISO Holding Corp.
  • Janssen Diagnostics, Inc.
  • Johnson and Johnson Holdings (Nevada)
  • Synthes Industria and Comercio Ltda.
  • Johnson andvJohnson Prof. Company (PR) Inc
  • Janssen Cilag
  • Farmaceutica Limited.
  • Janssen Inc. Ethicon Puerto Rico LLC
  • Obtech Medical, Inc.
  • Janssen Ortho Patient Asst. Found.
  • McNeil Healthcare LLC
  • Janssen Pharmaceuticals, Inc.
  • Johnson and Johnson do Brasil Indústria e Comércio de Produtos para Saúde Limited
  • Jevco Holding, Inc.
  • Johnson and Johnson Commercio E Distribuicai Limited.
  • JJHC LLC
  • Cilag Farmaceutica Limited
  • JJVC, Inc.
  • McNeil PDI Canada Inc.
  • McNeil Consumer Pharmaceuticals Co.
  • Odonto Corporation Limited
  • Johnson and Johnson Baby Products Inc
  • JandJ Brazil
  • Johnson and Johnson Intervt'l Sys.Inc
  • LifeScan Canada Limited
  • Johnson and Johnson Consumer Inc.
  • LifeScan Scotland Limited
  • Johnson and Johnson Development Cap. Limited
  • Diabetes Diag Int'l GmbH
  • J and J Development Corporation
  • Johnson and Johnson Inc.
  • J and J Family of Contribution Fund
  • Depuy (Canada) Limited
  • Johnson and Johnson Finance Corp.
  • Lifescan LLC
  • Johnson and Johnson Gateway LLC
  • Lifescan Products LLC
  • Johnson and Johnson HCS Inc.
  • Prod Desbiens Partnership
  • Johnson and Johnson International
  • Janssen Ortho Inc.
  • Johnson and Johnson Japan Inc.
  • Johnson and Johnson Products Inc
  • Johnson and Johnson Mgt. Services Inc
  • J and J Medical Products Limited
  • J and J Med. Devices and Diag. Grp LA LLC
  • Synthes Chile SpA
  • Johnson and Johnson Medical S.A. Inc.
  • Johnson and Johnson de Chile, S.A.
  • Johnson and Johnson Pediatric Inst.
  • Johnson and Johnson Personal Care (Chile) S.A.
  • Janssen Research and Development, LLC
  • Johnson and Johnson Chile Limited
  • Janssen Global Services, LLC
  • Productos De Cuidado Personal Y De La Salud De Bolivia S.R.L (Prosabol S.R.L.)
  • Johnson and Johnson Pharm. Trading Co
  • Synthes Peru S.A.C.
  • Codman and Shurtleff Inc
  • Synthes Costa Rica CS, Ltda
  • Johnson and Johnson S.C., Inc.
  • Johnson and Johnson de Colombia S.A.
  • Johnson and Johnson S.E., Inc.
  • Johnson and Johnson del Peru S.A.
  • Johnson and Johnson Services Inc.
  • Johnson and Johnson del Paraguay S.A.
  • J and J Shared Services Co (P.R.) Inc
  • Johnson and Johnson de Costa Rica, S.A.
  • Johnson and Johnson Shellco Inc.
  • JNJ Global Business Services s.r.o.
  • Johnson and Johnson Urban Ren. Assoc.
  • Compeed ApS
  • Johnson and Johnson Vision Care, Inc.
  • UAB Johnson and Johnson
  • Joint Medical Products Corporation
  • McNeil Denmark ApS
  • JCPI Corporation
  • McNeil Esbjerg ApS
  • Lifescan Inc.
  • Johnson and Johnson, filial af
  • Johnson and Johnson AB,  Sverige
  • LXN Corporation
  • Johnson and Johnson (Trinidad) Limited
  • Magnolia Nutritionals LLC
  • Johnson and Johnson (Jamaica) Limited
  • McNeil Nutritionals LLC
  • Johnson and Johnson Dominicana, C. por A.
  • McNeilPPC, Inc.
  • Johnson and Johnson Hemisferica S.A.
  • Medix Pharmaceuticals Americas Inc
  • Johnson and Johnson del Ecuador S.A.
  • Micro Typing Systems Inc.
  • J and J El Salvador
  • Middlesex Assurance Company Limited
  • Johnson and Johnson (Egypt) S.A.E.
  • Revite Urban Renewal Associates
  • Janssen Egypt Netherlands Holding Company
  • Synthes Sp.z.o.o.
  • Neutrogena Corporation
  • RoC International SA
  • Nitinol Development Corporation
  • Johnson and Johnson (Poland) Sp. z.o.o.
  • Noramco, Inc.
  • Johnson and Johnson N.V./S.A.
  • NVC, Inc.
  • Janssen Cilag Polska Sp. z o.o.
  • OMJ Pharmaceuticals IncMfg.
  • Janssen Cilag S.A.S.
  • OraPharma Inc.
  • Societe Micta
  • On Site/ Alza Joint Venture
  • Solucal
  • Janssen Services, LLC
  • Ethicon S.A.S.
  • Ortho Biotech Holding Corp.
  • Laboratoire Medix SAS
  • Janssen Biotech, Inc.
  • Kerapharm SAS
  • Janssen Products, LP
  • AC2 SAS
  • OCD Inc.
  • Johnson and Johnson Consumer
  • Holdings France S.A.S
  • Ortho McNeil
  • Finance Company
  • Biapharm SAS
  • Janssen Scientific Affairs, LLC
  • SAS Holding CEW
  • Janssen OrthoMcNeil Primary Care, Inc.
  • Ortho Clinical Diagnostics S.A.
  • Patriot Pharmaceuticals LLC
  • EvoTech GmbH
  • Peninsula Pharmaceuticals Inc.
  • APSIS S.A.R.L.
  • Princeton Laboratories Inc.
  • Vania Expansion Procait Foundation, Inc.
  • Laboratoires Polive
  • Raritan Advertising Inc.
  • Ratio Orthopadie GmbH
  • Regency Urban Renewal Ass.
  • Pamerland SCI Rutan Realty LLC
  • Depuy France S.A.S
  • Scios Inc.
  • Depuy Orthopedie S.A.S.
  • Scios RandD Inc. Depuy Bioland S.A.
  • Somerset Laboratories Inc.
  • DePuy Spine SarL
  • TERAMed Corporation
  • Medos International Sarl
  • The Tylenol Company
  • Johnson and Johnson Financial Services G.m.b.H.
  • Therapeutic Discovery Corporation
  • Johnson and Johnson Holdings
  • GMBH TransForm
  • Pharmaceuticals
  • Cordis Medizinische Apparate G.M.B.H.
  • Veridex, LLC
  • Penaten Gmbh Vistakon Pharmaceuticals LLC
  • Dr. Riese GmbH
  • Winthrope and Valentine Inc.
  • Care4S GmbH
  • Alza International Ethicon G.m.b.H.
  • Johnson and Johnson/ MSD
  • Cons. Corp. Finsbury GmbH
  • Centocor Biologics LLC (St. Louis)
  • Apsis GmbH (Germany)
  • Depuy Spine Inc.
  • I3G Institut fuer Innovation und Integration im Gesundheitswesen GmbH
  • Johnson and Johnson Sales and Logis. Co
  • Neuromuscular Electrical Stimulation Systems Limited
  • Hand Innovations LLC
  • Depuy Orthopedic GMBH
  • Animas Corporation
  • Landos Orthopaedie GMBH
  • Animas Holdings Inc.
  • Depuy Biotech Animas Diabetes Care LLC
  • Ethicon Endo Surgery G.m.b.H.
  • McNeil Puerto Rico Inc.
  • Biosense Israel Limited
  • Sweet Franchise, Inc.
  • EES Holdings de Mexico S. de R.L. de C.V.
  • Expanded Optics Incorporated Obtech Medical Mexico S.A. de C.V.
  • MTS Instruments, Inc.
  • Colbar Lifescience Limited
  • Ensure Medical, Inc.
  • Ortho Clinical
  • Diagnostics GmbH
  • Vascular Controls Systems
  • Johnson and Johnson G.m.b.H.
  • JOM Pharmaceutical Services, Inc.
  • Johnson and Johnson Group
  • Holdings GmbH Advanced
  • Technologies and Regenerative
  • Medicine, LLC
  • Dr. Carl Hahn G.m.b.H.
  • Conor Medsystems, Inc
  • Janssen Cilag Germany
  • BC Maya's Mom
  • Johnson and Johnson Hellas S.A.
  • McNeil Consumer Healthcare Latin America LLC
  • Janssen Cilag Pharmaceutical S.A.C.I.
  • The Vision Care Institute, LLC
  • DePuy Hellas S.A.
  • Children With Diabetes, Inc.
  • Johnson and Johnson Hellas Consumer Products Commercial Societe Anonyme
  • Johnson and Johnson Diabetes Institute, LLC
  • Johnson and Johnson Guatemala, S.A.
  • SurgRX Inc.
  • Ethnor Guatemala,
  • Sociedad Anonima SymCare
  • Johnson and Johnson de
  • Honduras S.A.
  • Wellness and Prevention, Inc.
  • Synthes (Hong Kong) Limited
  • Omrix Biopharmaceuticals, Inc
  • Johnson and Johnson Pte Limited Taiwan Branch
  • Mentor Worldwide LLC
  • Johnson and Johnson Consumer (Hong Kong) Limited
  • Inform Solutions, Inc
  • Johnson and Johnson (Hong Kong) Limited
  • Mentor Biologics, Inc
  • Synthes Medical
  • Private Limited
  • Mentor Texas GP LLC
  • PT Integrated Healthcare Indonesia
  • Mentor Texas LP P.T.
  • Johnson and Johnson Indonesia
  • Byron Medical, Inc. Synthes Medical
  • Ireland Limited
  • Mentor International Sales Corp
  • Janssen Alzheimer Immunotherapy (Holding) Limited Inc
  • Janssen Immunotherapy
  • AUB Holdings LLC JHC Ireland
  • Mentor International Holdings Alpha, Inc.
  • Latam International Investment Company
  • Mentor International Holdings Beta, Inc
  • Janssen Biologics Ireland
  • Mentor International
  • Holdings Delta, Inc
  • Latam Properties Holdings
  • Mentor Biopharmaceuticals, Inc
  • Cordis Cashel Limited
  • Melene Corp Janssen
  • Pharmaceutical Limited
  • Mentor Minnesolta, Inc
  • Johnson and Johnson European Treasury Company
  • Mentor Manufacturing, Inc.
  • Johnson and Johnson Luxembourg Finance Company
  • Mentor Merger Sub, Inc.
  • Turnbuckle Limited
  • Mentor International Sales Corporation (FSC)
  • OMJ PR Holdings
  • Mentor Partnership Holding Company I, LLC’
  • Conor Medsystems International Limited
  • Mentor International Holdings Camda, Inc
  • Conor Medsystems Ireland Limited
  • Dutch Holding LLC Alec Medical Limited
  • JNJ International Investment LLC
  • Synthes Luxembourg, S.Ă .r.l.
  • JNJ Irish
  • Investments ULC
  • Johnson and Johnson (Ireland) Limited
  • Janssen Oncology, Inc.
  • Drumbeat Limited
  • Janssen Alzheimer
  • Immunotherapy Research and Development, LLC
  • Johnson and Johnson Vision Care (Ireland) Limited
  • The DePuy Institute, LLC
  • PFIZER CONSUMER HEALTHCARE IRELAND
  • RedScript Ventures LLC
  • GMED Health Care Limited
  • Acclarent, Inc.
  • Johnson and Johnson K.K.
  • Finsbury
  • Orthopaedics Inc.
  • Johnson and Johnson Japan, Inc.
  • Micrus Endovascular Corporation
  • OrthoClinical
  • Diagnostics K.K.
  • Medical Devices and Diagnostics Global
  • Services, LLC
  • Johnson and Johnson (Kenya) Limited
  • Crucell Holdings Inc.
  • Johnson and Johnson Korea
  • Crucell Vaccines Inc.
  • Johnson and Johnson Sdn. Bhd.
  • Crucell Biologics Inc.
  • E.E.S., S.A. de
  • C.V. Mexico
  • McNEIL MMP, LLC Ethicon Foreign
  • Sales Corporation
  • BluFlex, LLC Cordis de Mexico S.A. de C.V.
  • SterilMed, Inc. JandJ Mexico S.A.
  • SterilMed Holdings, Inc.
  • Johnson and Johnson, S.A. DE C.V.
  • Refresh Holdings, Inc.
  • JandJ Medical Mexico S.A.
  • SterilMed Repair Corp.
  • Depuy Mexico S.A. de C.V.
  • Samson Acquisition Corp
  • JHC Nederland B.V.
  • SYNTHES Inc
  • Johnson and Johnson Consumer BV
  • Synthes USA
  • Development Center, LLC
  • JJC Acquisition Company B.V.
  • HFSC Company
  • Ortho Clinical Diagnostics N.V.
  • Synthes LAT, Inc JanssenCilag Netherlands
  • Synthes USA, LLC
  • Pfizer Consumer Healtcare B.V.
  • Synthes USA
  • Sales, LLC
  • JNJ Holding EMEA B.V.
  • Synthes USA
  • Products, LLC
  • Healthy Solutions
  • B.V. (former JandJ
  • Real Synthes USA HQ, Inc.
  • Johnson and Johnson (New Zealand) Limited
  • The Anspach Effort, Inc.
  • JanssenCilag Pty Limited
  • Synthes Corporate, Inc.
  • Ethnor del Istmo, S.A.
  • Subsidiary Canada, Inc.
  • McNeil Panama, LLC
  • N Spine, Inc.
  • Johnson and Johnson Panama, S.A.
  • Spine Solutions, Inc.
  • Johnson and Johnson (Philippines) Inc.
  • JanssenCilag Kft.
  • Alza Ireland Limited JanssenCilag .s.r.o
  • Synthes S.A. Johnson and
  • Johnson Limitada
  • Janssen Cilag
  • N.V./S.A.
  • Johnson and Johnson (Angola)
  • Limitada
  • Janssen Cilag
  • International NV
  • Johnson and Johnson (Mozambique) Lda
  • Tarpon Company Limited
  • Representative Office of Johnson and Johnson LLC
  • (Russian Federation) Synthes Canada, Limited
  • Representative Office of Johnson and Johnson Limited
  • Liability Company in Kazakhstan Janssen
  • Pharmaceutica Inc.
  • JanssenCilag
  • Polska Spolka Z
  • Ograniczona
  • Odpowiedzialnoscia
  • Oddzial W Rydze
  • Synthes (Suzhou)
  • Medical Co., Limited
  • Janssen Cilag
  • Manufacturing, LLC
  • Xian Janssen
  • Pharmaceutical Limited
  • Johnson and Johnson Estonia
  • Beijing Dabao
  • Cosmetics Co,Limited
  • Johnson and Johnson Latvia
  • Healthcare Services (Shanghai) Limited
  • Johnson and Johnson International (Singapore) PTE. LIMITED
  • Johnson and Johnson Medical China
  • Johnson and Johnson Vision Care (Shanghai) Limited
  • Representative Office of Johnson and Johnson LLC
  • Johnson and Johnson Medical
  • Suzhou Limited
  • Synthes Singapore Pte Limited
  • Johnson and Johnson Medical
  • Shanghai Limited
  • Johnson and Johnson Medical (Pty) Limited
  • Synthes (Shanghai) Medical
  • Trading Co., Limited
  • JanPharm (Pty) Limited
  • Synthes Hong Kong Holdings Limitedi cal Trading Co., Limited
  • SYNTHES (PROPRIETARY) Limited
  • Guangzhou Bioseal Biotechnology Co., Limited
  • Ethnor (Pty.) Limited
  • Janssen Cilag S.A. Robenhill Farm (Pty.) Limited
  • Mc Neil LA LLC
  • Johnson and Johnson (Pty.) Limited
  • Synthes Colombia S.A.S.
  • Janssen Pharmaceutica (Pty.) Limited
  • Synthes S.r.o. Laboratorios Visine SL
  • Johnson and Johnson, s.r.o.
  • McNeil Iberica SL (form. Abello Pharmaceutica S.L.
  • Johnson and Johnson, s.r.o.
  • McNeil Consumer Healthcare SLU
  • Synthes Colombia S.A.S.
  • Johnson and Johnson, S.A.
  • Janssen Cilag A/S McNeil AB
  • Janssen Cilag OY McNeil Sweden AB
  • Synthes A/S ACO AB
  • Synthes Oy Backsvalan AB
  • Synthes Amic Production AB
  • McNeil Santé Grand Public SAS
  • Johnson and Johnson Vision Products AB
  • McNeil Mfg SAS Amic AB
  • JandJ Medical SARL Cilag GmbH International
  • Cordis SA (France)
  • Cilag Pharmaceuticals GmbH
  • Etablissements RUBY S.A.
  • Future Medical System S.A.
  • McNeil S.A.S. (form. Laboratoires
  • Martin Johnson and Gloster Europe SAS
  • Johnson and Johnson AG
  • Switzerland Cordis AG (Switzerland)
  • Johnson and Johnson Sante Beaute France
  • Janssen Cilag
  • Pharma GmbH
  • FMS FRANCE S.A. Synthes
  • Oesterreich GmbH
  • Future Medical
  • Systems S.A.
  • Cilag Holding AG
  • Cilag Advanced Technologies GmbH
  • Cilag AG
  • Synthes GmbH
  • McNeil Consumer Nutritionals GmbH
  • Synthes Finanz AG
  • ETHICON
  • Women's Health and Urology Sarl
  • Synthes Bettlach GmbH
  • The R.W. Johnson
  • Pharmaceutical
  • Research Inst
  • Almaco Holding AG
  • Medos Sarl
  • Synthes Lux
  • Holding S.Ă .r.l
  • Johnson and Johnson Taiwan, Limited
  • Synthes Lux Finance S.Ă .r.l.
  • Johnson and Johnson (HK) Limited Taiwan Branch
  • Synthes Produktions GmbH
  • Synthes Medical Taiwan Ltd
  • Synthes Holding AG
  • Johnson and Johnson (Thailand) Limited
  • Pfizer Consumer Healthcare GmbH
  • Personal Prod. Thailand
  • Pfizer CHC GmbH
  • Johnson and Johnson Middle East Synthes
  • Deutschland Holding GmbH
  • JC Health Care Limited
  • Innomedic Ges. fĂ¼r innov. Medizintechnik u. Info
  • Johnson and Johnson Middle
  • East FZLLC Synthes Tuttlingen GmbH
  • Synthes Medical
  • Surgical Equipment and Instruments Trading LLC,
  • Arab Emerites
  • Synthes Medical Immobilien GmbH
  • Synthes Holding Limited
  • Synthes GmbH Micrus
  • Endovascular UK LIMITED
  • Spine Solutions GmbH
  • Johnson and Johnson Management Limited
  • Codman Neuro Sciences SarL
  • Johnson and Johnson Medical Limited
  • Corimmun GmbH JandJ Investments Limited
  • McNeil Gmbh and Co. OHG (form. Woelm Pharma GmbH and C
  • Johnson and Johnson Medical (2004) Limited
  • McNeil GmbH and Co.
  • Arzneimittelvertr Cordis U.K., Limited
  • McNeil Verwaltungs GmbH
  • (fka Woelm Pharma Verwaltu High Wycombe Property Management Limited
  • EUROflex GmbH
  • JanssenCilag Limited Ireland
  • Synthes Medical Kft.
  • Ethicon PR Holdings
  • Johnson and Johnson Romania S.R.L.
  • Cougar Biotechnology Limited
  • Johnson and Johnson Kft. Conor Medsystems UK Limited
  • Johnson and Johnson S.p.A.
  • Finsbury Orthopaedics Limited
  • Carlo Erba OTC S.r.l.
  • Johnson and Johnson Consumer
  • Healthcare S.r.l.
  • Finsbury (Development) Limited
  • Mc Neil Italia S.r.l.
  • Finsbury Orthpaedics
  • International Limited
  • Janssen Cilag S.p.A.
  • JandJ Consumer
  • Services EMAE., Limited
  • Synthes S.R.L.
  • McNeil Nutritionals
  • Limited (fka McNeil
  • Consumer Mu (form. Centra Medicamenta OTC SrL
  • Finsbury Medical Limited
  • DePuy Motion Sarl
  • McNeil Limited fka Johnson and Johnson MSD Consumer
  • Janssen Pharmaceutical K.K.
  • Johnson and Johnson Finance Limited
  • Synthes K.K.
  • Johnson and Johnson Swiss Finance Company Limited
  • Cordis Holding Italy S.r.l.
  • Finsbury Orthopaedics International Limited
  • Janssen Cilag KK
  • JANSSENCILAG NEW ZEALAND) LIMITED
  • Modesto K.K.
  • Finsbury Orthopaedics International Limited
  • K. K. Depuy Japan Johnson and
  • Johnson Limited Janssen Korea, Limited
  • Pfizer Consumer Healthcare Company
  • Synthes Korea Limited
  • Pfizer Consumer Health Products Company
  • Johnson and Johnson Medical Korea (Limited)
  • Unicliffe Limited
  • Synthes Korea Limited
  • Ortho Clinical Diagnostics U.K.
  • Johnson and Johnson Korea Sales and Distribution LLC
  • DePuy UK Holdings Limited
  • Johnson and Johnson Pte. Limited Korea Branch
  • Depuy Int'l Limited
  • Johnson and Johnson Medical
  • Mfg. Sdn. Bhd
  • Depuy Int'l (Holdings) Limited
  • Synthes Malaysia Sdn Bhd
  • Acromed U.K. Limited
  • Janssen Cilag de Mexico S. de R.L. de C.V.
  • Tweedbank Surgical Engineering Limited
  • Synthes S.M.P. de S.A. de C.V
  • DePuy Motech Limited
  • Johnson and Johnson Servicios
  • Corporativos S. de R.L. de C.V.
  • Johnson and Johnson de Venezuela, S.A.
  • Janssen de Mexico S. de R.L. de C.V.
  • Ethnor Farmaceutica, S.A.
  • JandJ Medical
  • Devices and Diag. LA
  • JanssenCilag C.A.
  • Johnson and Johnson Morocco S.A.
  • Johnson and Johnson Medical Sociedad en Comandita Simple
  • Johnson and Johnson Medical S.p.A.
  • European Logistics Center
  • Synthes B.V., Zeist Ethicon SarL
  • Johnson and Johnson Medical BV
  • Omrix Biopharmaceuticals, Limited
  • Cordis Europa N.V. (Netherlands)
  • Mentor Medical Systems, C.V.
  • Janssen Biologics BV
  • Mentor Holding PP, SAS
  • CNA Development LLC
  • Perouse Plastie, SAS
  • Johnson and Johns0on Pakistan (Private) Limited
  • PP SUD Limited
  • Janssen Farmaceutica (Portugal) Lda.
  • MDI Company Limited
  • Janssen Cilag
  • Farmaceutica, Lda.
  • Mentor Aesthetics Europe B.V.
  • Synthes Comercializaçao de Dispositivos Medic
  • Mentor Biopolymers Limited
  • Janssen Cilag S.A. (formerly Janssen Sp)
  • Mentor Medical Systems (Aust) Pty Limited
  • Cilag Biotech, S.L.
  • Mentor Medical Systems Benelux B.V.
  • Janssen Pharma, S.L.
  • Mentor Medical Systems Canada Synthes Stratec S.A.
  • Mentor Medical Systems Iberica S.L.
  • Synthes AS
  • Mentor Medical Systems Italia, S.r.L.
  • Johnson and Johnson AB
  • Mentor Medical Systems Limited
  • Janssen Cilag Norway
  • Mentor Deutschland GmbH
  • Janssen Cilag Sweden AB Biopex Limited
  • Synthes AB Mentor Medical Systems, B.V.
  • Johnson and Johnson AB
  • Omrix Biopharmaceuticals, S.A.
  • J and J Holding AB Sweden
  • Omrix Biopharmaceuticals GmBH
  • QBU USD Cilag Gmbh International
  • Johnson and Johnson Medical S.A. Inc.
  • QBU GBP Cilag Gmbh International
  • Berna Rhein B.V.
  • Janssen Cilag Switzerland
  • Crucell Switzerland AG
  • Depuy Olmed AB Crucell Holland B.V.
  • Crucell N.V. Crucell Sweden AB
  • Cemvac Systems AB
  • Crucell UK Limited
  • DePuy Mitek Sarl Crucell Italy Srl
  • Janssen Cilag Limited Berna Biotech
  • Korea Corporation
  • Johnson and Johnson Consumer (Thailand) Limited
  • Crucell Spain S.A.
  • Johnson and Johnson (Vietnam) Co., Limited

 

 

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2014

 

Authorized Capital:

 

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.100/- each

Rs.150.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital:

 

No. of Shares

Type

Value

Amount

 

 

 

 

1440000

Equity Shares

Rs.100/- each

Rs.144.000 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[All figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

144.000

144.000

144.000

(b) Reserves & Surplus

11972.700

11433.800

8054.600

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

12116.700

11577.800

8198.600

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) Long-term provisions

1074.400

1027.200

1213.100

Total Non-current Liabilities (3)

1074.400

1027.200

1213.100

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

7965.600

6929.700

5993.800

(c) Other current liabilities

1083.600

986.400

925.600

(d) Short-term provisions

1351.300

193.500

224.800

Total Current Liabilities (4)

10400.500

8109.600

7144.200

 

 

 

 

TOTAL

23591.600

20714.600

16555.900

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3633.900

3415.200

2955.300

(ii) Intangible Assets

1367.300

1317.500

1556.800

(iii) Capital work-in-progress

559.500

415.200

237.200

(iv) Intangible assets under development & work-in-progress

0.000

1.100

0.000

(b) Non-current Investments

0.100

0.100

0.100

(c) Deferred tax assets (net)

339.700

191.400

242.500

(d)  Long-term Loan and Advances

2690.700

2776.900

2815.500

(e) Other Non-current assets

141.100

125.400

0.000

Total Non-Current Assets

8732.300

8242.800

7807.400

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

5886.000

4479.700

3994.000

(c) Trade receivables

3508.700

3074.000

2509.700

(d) Cash and cash equivalents

3445.100

2598.900

483.700

(e) Short-term loans and advances

646.400

688.200

633.900

(f) Other current assets

1373.100

1631.000

1127.200

Total Current Assets

14859.300

12471.800

8748.500

 

 

 

 

TOTAL

23591.600

20714.600

16555.900

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Revenue from operations

39716.600

35521.400

29294.000

 

 

Other Income

621.900

359.700

304.200

 

 

TOTAL                                     (A)

40338.500

35881.100

29598.200

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

6941.400

5663.300

5307.400

 

 

Purchases of stock-in-trade

8813.100

8668.900

7421.200

 

 

Changes in inventories of finished goods, work-in-progress and

stock-in-trade

(1024.100)

(290.000)

(1318.700)

 

 

Employee benefit expense

5105.200

4482.700

3812.200

 

 

Other expenses

13959.600

12404.500

11578.600

 

 

TOTAL                                     (B)

33795.200

16887.200

15390.800

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

6543.300

4951.700

2797.500

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

0.000

0.000

37.200

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

6543.300

4951.700

2760.300

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

1028.500

840.800

762.600

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

5514.800

4110.900

1997.700

 

 

 

 

 

Less

TAX                                                                  (H)

1461.400

731.700

230.900

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

4053.400

3379.200

1766.800

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

2312.500

1319.700

1570.359

 

 

Rebate on Imports

0.000

0.000

23.204

 

 

Other Earnings

2751.900

2834.900

1886.290

 

 

Sales of Business

0.000

0.000

255.083

 

TOTAL EARNINGS

5064.400

4154.600

3734.936

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

2249.500

1777.600

6817.900

 

 

Finished Products

5307.600

5138.400

0.000

 

 

Stores & Spares

9.800

24.400

20.200

 

 

Capital Goods

271.600

366.100

269.800

 

TOTAL IMPORTS

7838.500

7306.500

7107.900

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

2815.00

2347.00

1227.00

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Net Profit Margin

PAT / Total Income

(%)

10.21

9.51

6.03

 

 

 

 

 

Operating Profit Margin

(PBT/Sales)

(%)

16.47

13.94

9.55

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

24.30

20.45

12.43

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.46

0.36

0.24

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.43

1.54

1.22

 

 

FINANCIAL ANALYSIS

[All figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

144.000

144.000

144.000

Reserves & Surplus

8054.600

11433.800

11972.700

Net worth

8198.600

11577.800

12116.700

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

29294.000

35521.400

39716.600

 

 

21.258

11.810

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

29294.000

35521.400

39716.600

Profit

1766.800

3379.200

4053.400

 

6.03%

9.51%

10.21%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No 

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No 

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

LITIGATION DETAILS:

 

CASE DETAILS

Bench:- Bombay

Presentation Date:- 18.07.2014

Stamp No:-

ITXAL/1350/2014

Failing Date:-

18.07.2014

Reg. No.:

ITXA/1291/2014

Registrar Date:

--

Petitioner:-

THE COMMISSIONER OF INCOME TAX

Respondent:-

JOHNSON AND JOHNSON LIMITED

Petn.Adv:-

A R MALHOTRA (0)

 

District:-

MUMBAI

Bench:-

SINGLE

Status:-

Pre-Admission

Category:-

TAX APPEALS

Last Date:-

30.10.2014

Stage:-

FOR REJECTION (ORIGINAL SIDE MATTERS)

Last Coram:-

REGISTRAR(OS)/PROTHONOTARY AND SR. MASTER

Act:-

Income Tax Act, 1961

Under Section:-

-

 

 

PROFITS

 

The profit for the year after tax amounted to Rs.4053.400 millions as compared to the profit of Rs. 3379.200 millions for the previous year.

 

 

 

BUSINESS SEGMENTS

 

The Company has considered business segment as the primary segment for disclosure. The products included in each of the reported domestic business segments are as follows:

 

Consumer

 

Consumer includes baby care products (soap, powder, cream, shampoo, ear buds, oil etc.), women hygiene and personal care products (sanitary napkins), wound care products (adhesive bandages and antiseptic liquid), oral care, over the counter and skin adult care products (prickly heat powder and face wash).

 

Pharmaceutical

 

Pharmaceutical includes products in the categories of prescribed drugs.

 

Medical

 

Medical includes surgical sutures, hospital products, various surgical and surgeon related equipment’s, Ortho Clinical Diagonstic Equipments like blood testing equipment’s and disposable eye lenses.

 

 

NOTE:

 

Registered office has been shifted from Spencer Ls Building, 30, Forjett Street, August Kranti Road, Mumbai-400 036, Maharashtra, India to the present address w.e.f. 09.02.2014.

 

 

FIXED ASSETS

 

Tangible Assets

·         Land Improvement

·         Buildings

·         Building Improvements

·         Machinery and Equipment

-          Air/water pollution

-          Fire protection equipment’s

-          Demonstration equipment’s

-          Testing equipment’s

-          Dies and Moulds

-          Other plant, machinery, equipment’s and electrical installations

·         Computers

-          Personal computers

-          Data processing machines

·         Vehicles

·         Office Equipments

-          Mobile phones

-          Home appliances

-          Other office equipment’s

·         Office Furniture

 

Intangible Assets

·         Trade Marks

·         Intellectual Property Rights

·         Marketing Licence Fees

·         Software

 

INDEX OF CHARGES:

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

90188769

08/06/1999

100,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH, JUSTICE GNVAIDAYA MARG, MUMBAI, MAHARASHTRA - 400023, INDIA

-

2

90186640

05/02/1999

100,000,000.00

THE HONG KONG AND SHANGHAI BANKING CORPORATION LTD 
.

52/60; MAHATMA GANDHI ROAD, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

-

3

90185838

30/06/1992

17,000,000.00

IDBI BANK LTD.

IDBI TOWER, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

4

90185835

22/06/1992

17,000,000.00

IDBI BANK LTD.

IDBI TOWER, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

5

90188006

20/08/1990 *

400,000.00

THE HONG KONG AND SHANGHAI BANKING CORPORATION LTD 
.

52/60; MAHATMA GANDHI ROAD, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

-

Date of charge modification

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.65

UK Pound

1

Rs.97.54

Euro

1

Rs.76.69

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUM

 

 

Analysis Done by :

KRN

 

 

Report Prepared by :

MTN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

8

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

8

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

72

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.